shown that such processes can be extended to a variety of
partners such as allenynes9 and ene-tosylynamides.10 More-
over, as was the case for dienynol derivatives,11 it has been
shown that in acyclic 5-en-1-yn-3-ol precursors 1 the nature
of the hydroxy protecting group at the propargylic position
is a very practical handle for controlling the outcome of the
reaction.12 When this function is free, or appears as a silyl
ether, bicyclic compound 3 is formed, while bicyclic enol
ester 2 is isolated when an O-acyl group is present (Scheme
1). Electrophilic activation of the alkyne moiety triggers at
products possess a related tricycloundecane framework (n
) 5, m ) 1) such as anastreptene15 or myliol16 isolated from
liverwort plants. Some others, such as euphanginol17 (n )
2, m ) 4) and favelanone18 (n ) 4, m ) 2), are obtained
from Euphorbia species which present some antitumoral or
cytotoxic activities (Scheme 2).
Scheme 2. Transannular PtCl2-Catalyzed Cyclopropanation
Strategy
Scheme 1. PtCl2-Catalyzed Cyclizations of Acyclic 1,5-Enyne
Derivatives 1
will a hydride or an O-acyl migration yielding to regioiso-
meric derivatives.
Since the macrocycles we have designed originate from
the macrocylization of R,ω-ynal precursors by using the
Nozaki-Hiyama-Kishi-Takai (NHKT) chromium(II)-
mediated process,13 they display the pivotal propargyl alcohol
motif and so constitute ideal test substrates.
Thus, we anticipated that enyne macrocycle precursors of
type 4 would undergo transannular cyclopropanations which
would constitute a straightforward, modular, and unprec-
edented access to highly valuable tricyclic derivatives 5
incorporating an inner cyclopropane moiety.14 Various natural
Herein, we report the application of this transannular
strategy to various 1,5-unsaturated eleven-membered rings
such as cycloundecenynes 10 and 11 (Scheme 3) and
cycloundecadienynes Z,E- and E,E-17 (Scheme 6) whose
syntheses are, as previously mentioned, based on the efficient
NHKT macrocyclization conditions. Thus, following the
synthesis of the already described heptenal 6 as a TBS-
ether,19 we prepared it as a THP derivative. This one was
first submitted to Horner-Wadsworth-Emmons olefination
conditions modified by Masamune and Roush20 to reach
stereoselectively the corresponding E,E-nonadienoate 7.
Then, a five-step sequence including a LAH total reduction-
iodination-alkynylation-alkyne deprotection-ether depro-
tection furnished undecenynol 8 in 47% overall yield.
The macrocyclization precursor was prepared by mild
iodination of the triple bond, followed by IBX oxidation of
the alcohol moiety. Slow addition of the resulting unde-
cenynal to a suspension of chromium(II) chloride in THF
was performed to produce cleanly cycloundecenynol E-9 in
38% overall yield in three steps (Scheme 3).
(7) For reviews, see: (a) Aubert, C.; Buisine, O.; Malacria, M. Chem.
ReV. 2002, 102, 813-834. (b) Me´ndez, M.; Mamane, V.; Fu¨rstner, A.
Chemtracts-Org. Chem. 2003, 16, 397. (c) Lloyd-Jones, G. C. Org. Biomol.
Chem. 2003, 1, 215-236.
(8) For recent publications, see: (a) Nevado, C.; Ca´rdenas, D. J.;
Echavarren, A. M. Chem. Eur. J. 2003, 9, 2627-2635. (b) Chatani, N.;
Kataoka, K.; Murai, S.; Furukawa, N.; Seki, Y. J. Am. Chem. Soc. 1998,
120, 9104-9105. (c) Trost, B. M.; Doherty, G. A. J. Am. Chem. Soc. 2000,
122, 3801-3810. (d) Charruault, L.; Michelet, V.; Taras, R.; Gladiali, S.;
Geneˆt, J.-P. Chem. Commun. 2004, 850-851. (e) Fu¨rstner, A.; Stelzer, F.;
Szillat, H. J. Am. Chem. Soc. 2001, 123, 11863-11869. (f) Me´ndez, M.;
Mun˜oz, M. P.; Nevado, C.; Ca´rdenas, D. J.; Echavarren, A. M. J. Am. Chem.
Soc. 2001, 123, 10511-10520.
(9) Cadran, N.; Cariou, K.; Herve´, G.; Aubert, C.; Fensterbank, L.;
Malacria, M.; Marco-Contelles, J. J. Am. Chem. Soc. 2004, 126, 3408-
3409.
(10) Marion, F.; Coulomb, J.; Courillon, C.; Fensterbank, L.; Malacria,
M. Org. Lett. 2004, 6, 1509-1511.
(11) Mainetti, E.; Mourie`s, V.; Fensterbank, L.; Malacria, M. Marco-
Contelles, J. Angew. Chem., Int. Ed. 2002, 41, 2132-2135.
(12) (a) Harrak, Y.; Blaszykowski, C.; Bernard, M.; Cariou, K.; Mainetti,
E.; Mourie`s, V.; Dhimane, A.-L.; Fensterbank, L.; Malacria, M. J. Am.
Chem. Soc. 2004, 126, 8656-8657. For similar findings, see: (b) Mamane,
V.; Gress, T.; Krause, H.; Fu¨rstner A. J. Am. Chem. Soc. 2004, 126, 8654-
8655.
(13) (a) Takai, K.; Kuroda, T.; Nakatsukasa, S.; Oshima, K.; Nozaki, H.
Tetrahedron Lett. 1985, 26, 5585-5588. (b) Rychlet Elliott, M.; Dhimane,
A. L.; Hamon, L.; Malacria, M. Eur. J. Org. Chem. 2000, 155-163.
(14) For other access to these intriguing skeletons, see: (a) Hannah, D.
J.; Smith, R. A. J.; Teoh, I.; Weavers, R. T. Aust. J. Chem. 1981, 34, 181-
188. (b) Marshall, J. A.; Peterson, J. C.; Lebioda, L. J. Am. Chem. Soc.
1984, 106, 6006-6015. (c) Ricci, A.; Fasani, E.; Mella, M.; Albini, A. J.
Org. Chem. 2003, 68, 4361-4366.
(15) Warmers, U.; Ko¨nig, W. A. Phytochemistry 1999, 52, 1519-1524.
(16) Hayashi, K.-I.; Asano, K.-I.; Tanaka, M.; Takaoka, D.; Nozaki, H.
Phytochemistry 1998, 48, 461-466.
(17) Shi, J.-G.; Shi, Y.-P.; Jia, Z.-J. Phytochemistry 1997, 45, 343-
347.
(18) Endo, Y.; Ohta, T.; Nozoe, S. Tetrahedron Lett. 1991, 32, 5555-
5558.
(19) A¨ıssa, C.; Dhimane, A.-L.; Malacria, M. Synlett 2000, 1585-1588.
(20) Blanchette, M. A.; Choy, W.; Davis, J. T.; Essenfeld, A. P.;
Masamune, S.; Roush, W. R.; Sakai, T. Tetrahedron Lett. 1984, 25, 2183-
2186.
3772
Org. Lett., Vol. 6, No. 21, 2004